538 related articles for article (PubMed ID: 32493021)
61. Granulomatous Vasculitis.
Sharma A; Dogra S; Sharma K
Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
[TBL] [Abstract][Full Text] [Related]
62. Delta Neutrophil Index Is Associated with Vasculitis Activity and Risk of Relapse in ANCA-Associated Vasculitis.
Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Yonsei Med J; 2018 May; 59(3):397-405. PubMed ID: 29611402
[TBL] [Abstract][Full Text] [Related]
63. [Cortisone-free rheumatology-Vasculitides].
Holle JU; Moosig F
Z Rheumatol; 2021 May; 80(4):314-321. PubMed ID: 33709164
[TBL] [Abstract][Full Text] [Related]
64. The immunopathology of ANCA-associated vasculitis.
McKinney EF; Willcocks LC; Broecker V; Smith KG
Semin Immunopathol; 2014 Jul; 36(4):461-78. PubMed ID: 25056155
[TBL] [Abstract][Full Text] [Related]
65. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?
Erden A; Bolek EC; Yardimci KG; Kilic L; Bilgen SA; Karadag O
Int J Rheum Dis; 2019 Oct; 22(10):1926-1932. PubMed ID: 31571413
[TBL] [Abstract][Full Text] [Related]
66. Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients: Comparison With Idiopathic Pulmonary Fibrosis.
Kwon M; Lee AS; Mira-Avendano I; Rojas CA; Grage R; Abril A
J Clin Rheumatol; 2021 Dec; 27(8):324-330. PubMed ID: 32251058
[TBL] [Abstract][Full Text] [Related]
67. The initial predictors of death in 153 patients with ANCA-associated vasculitis in a single Korean centre.
Mun CH; Yoo J; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):65-72. PubMed ID: 29465370
[TBL] [Abstract][Full Text] [Related]
68. Key advances in the clinical approach to ANCA-associated vasculitis.
Kallenberg CG
Nat Rev Rheumatol; 2014 Aug; 10(8):484-93. PubMed ID: 24980139
[TBL] [Abstract][Full Text] [Related]
69. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
70. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
[TBL] [Abstract][Full Text] [Related]
71. [ANCA-associated small-vessel vasculitides].
Bayrashevskaya AV; Degtyareva ND; Radenska-Lopovok SG
Arkh Patol; 2022; 84(1):50-58. PubMed ID: 35166479
[TBL] [Abstract][Full Text] [Related]
72. [Anca-associated vasculitides in elderly people].
Jeleniewicz R
Wiad Lek; 2019; 72(9 cz 1):1691-1696. PubMed ID: 31586985
[TBL] [Abstract][Full Text] [Related]
73. Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria.
Pyo JY; Lee LE; Park YB; Lee SW
Yonsei Med J; 2023 Jan; 64(1):11-17. PubMed ID: 36579374
[TBL] [Abstract][Full Text] [Related]
74. Anti-Neutrophil Cytoplasmic Antibodies Positivity and Anti-Leukotrienes in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Monocentric Study on 134 Italian Patients.
Schroeder JW; Folci M; Losappio LM; Chevallard M; Sinico RA; Mirone C; De Luca F; Nichelatti M; Pastorello EA
Int Arch Allergy Immunol; 2019; 180(1):64-71. PubMed ID: 31189169
[TBL] [Abstract][Full Text] [Related]
75. Anti-neutrophil cytoplasmic antibodies-associated vasculitis: a guide and case study.
Boyer H; Mortimore G
Br J Nurs; 2020 Dec; 29(22):1333-1340. PubMed ID: 33325285
[TBL] [Abstract][Full Text] [Related]
76. Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis.
Willeke P; Schlüter B; Sauerland C; Becker H; Reuter S; Jacobi A; Schotte H
PLoS One; 2015; 10(9):e0137196. PubMed ID: 26339905
[TBL] [Abstract][Full Text] [Related]
77. Intravenous immunoglobulin therapy in antineutrophil cytoplasmic antibody-associated vasculitis.
Benavides-Villanueva F; Loricera J; Calvo-Río V; Corrales-Selaya C; Castañeda S; Blanco R
Eur J Intern Med; 2023 Nov; 117():78-84. PubMed ID: 37400322
[TBL] [Abstract][Full Text] [Related]
78. Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis.
Sebastiani M; Manfredi A; Vacchi C; Cassone G; Faverio P; Cavazza A; Sverzellati N; Salvarani C; Luppi F
Clin Exp Rheumatol; 2020; 38 Suppl 124(2):221-231. PubMed ID: 32324122
[TBL] [Abstract][Full Text] [Related]
79. [Pathophysiology of ANCA vasculitis].
Augusto JF; Brilland B
Nephrol Ther; 2023 Jun; 19(S1):30-38. PubMed ID: 37381742
[TBL] [Abstract][Full Text] [Related]
80. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
Chang DY; Li ZY; Chen M; Zhao MH
Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
